The Transmucosal Drug Delivery Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the transmucosal drug delivery devices has shown robust growth lately. The market is predicted to expand from $50.24 billion in 2024 to $55.04 billion in 2025 with a compound annual growth rate (CAGR) of 9.6%.
The market for transmucosal drug delivery devices is predicted to reach a size of $78.21 billion in 2029, growing at a compound annual growth rate of 9.2%.
Download Your Free Sample of the 2025 Transmucosal Drug Delivery Devices Market Report and Uncover Key Trends Now!The drivers in the transmucosal drug delivery devices market are:
• Increasing need for rapid relief from angina
• Growing recognition of the effectiveness of sublingual delivery for quick drug absorption
• Desire to evade gastrointestinal degradation of administered drugs
• Development and advancement of buccal tablets and non-invasive delivery of peptides and proteins
The transmucosal drug delivery devices market covered in this report is segmented –
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
The trends in the transmucosal drug delivery devices market are:
• Expansion in therapeutic applications is shaping the future of the transmucosal drug delivery devices market.
• Customization of drug delivery devices for personalized medicine is a rising trend.
• The market is being influenced by new regulatory approvals and guidelines.
• The development of eco-friendly devices and innovative formulations are emerging trends in the market.
The major players in the transmucosal drug delivery devices market are:
• Johnson & Johnson
• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Novartis AG
• Becton Dickinson and
North America was the largest region in the transmucosal drug delivery devices market in 2024